98%
921
2 minutes
20
Background: Our institution decided to implement an awake MRI scanning quality improvement project using audiovisual distraction (AVD) technology.
Objective: To reduce the utilization of minimal/moderate sedation by at least 20% in children 4 to 18 years, while maintaining comparable diagnostic quality and adhering to allotted exam times, through the implementation of an awake MRI program.
Materials And Methods: This project was conducted at a pediatric sedation clinic between October 2021 and January 2024. We included patients 4 to 18 years of age, scheduled for an MRI at the pediatric hospital, and eligible for either minimal/moderate sedation or AVD. The outcome measure was the percentage of patients referred to our sedation clinic who completed an MRI with AVD and without sedation, analyzed on a statistical process control (SPC) P-Chart. Process measures were the number of children eligible for AVD per month, analyzed on an SPC C-Chart. Balance measures were the number of studies that exceeded allotted exam time or were non-diagnostic.
Results: Of 734 MRI referrals aged 4 to 18 years, 320 patients met inclusion criteria. Two hundred twenty-eight (71.3%) received minimal/moderate sedation (mean age [SD] 9.7 years [± 3.0]) and 92 (28.8%) underwent AVD (mean age 10.0 years [± 2.7]). The average monthly decrease in minimal/moderate sedation use was 28.8 percentage points. The average number of children considered eligible for AVD increased by special cause variation from 3.8 to 7 patients per month. All 92 MRI referrals triaged to AVD completed their MRI successfully without sedation; all studies were diagnostic, and 96% of studies were within the allotted exam time.
Conclusion: We implemented an awake MRI program with AVD that decreased monthly sedation needs by 28.8 percentage points while maintaining a high rate of diagnostic studies and no MRI delays.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00247-025-06293-4 | DOI Listing |
Pediatr Radiol
August 2025
University of Wisconsin-Madison, H6/562 CSC, 600 Highland Ave, Madison, WI 53792, United States.
Background: Our institution decided to implement an awake MRI scanning quality improvement project using audiovisual distraction (AVD) technology.
Objective: To reduce the utilization of minimal/moderate sedation by at least 20% in children 4 to 18 years, while maintaining comparable diagnostic quality and adhering to allotted exam times, through the implementation of an awake MRI program.
Materials And Methods: This project was conducted at a pediatric sedation clinic between October 2021 and January 2024.
Semin Intervent Radiol
June 2024
Department of Radiology, Interventional Radiology, University of Colorado, Aurora, Colorado.
Minerva Gastroenterol (Torino)
December 2024
Gastroenterology and Digestive Endoscopy Unit, Azienda USL di Modena, Carpi, Modena, Italy.
Children (Basel)
April 2022
Facultad de Fisioterapia y Enfermería, Universidad de Castilla La Mancha, 45071 Toledo, Spain.
Objective: The objective of this study was to evaluate the efficacy and safety of intranasal midazolam as part of a paediatric sedation and analgesic procedure during the suturing of traumatic lacerations in paediatric emergency departments.
Methodology: A systematic review of clinical trials was completed in July 2021. The databases consulted were PUBMED, SCOPUS, WEB OF SCIENCE, NICE and Virtual Health Library.
Paediatr Anaesth
November 2019
Clinical Affairs, Advicenne, Nîmes, France.
One of the most widely used options for minimal/moderate sedation in pediatric patients is oral midazolam, as it presents an alternative to less well-accepted routes of administration (eg, intravenous or intranasal) of this well-known efficacious and well-tolerated short-acting benzodiazepine. A systematic review of the literature was conducted in order to identify clinical studies evaluating the effectiveness of oral midazolam for sedation in pediatric patients in the context of premedication before anesthesia or during diagnostic/treatment procedures. The percentage of responders (response rate) after single administration of oral midazolam was evaluated and compared versus placebo in a subset of placebo-controlled studies.
View Article and Find Full Text PDF